Institut Curie clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 134 studies whose lead sponsor is Institut Curie. 28 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.
Keep track of what changes. Save the Institut Curie studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Institut Curie leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 134. Browse all 134 →
- Optimizing Bronchopulmonary Cancer ScreeningRecruitingNCT06439901Not applicable
- COsegregation of VARiants in Panel of GenesRecruitingNCT01689584Not applicable
- Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)RecruitingNCT06225505Not applicable
- Validation of Capillary Microsampling for Therapeutic Drug Monitoring of CDK4/6 Inhibitors in Breast Cancer Patients (TDHOME)RecruitingNCT07491380Not applicable
- Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs)RecruitingNCT05558644Not applicable
- ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive CancersRecruitingNCT05441163Not applicable
- Omission of Surgery for Triple-negative Breast Cancer in Complete Response After Neoadjuvant Chemo-immunotherapyNot yet recruitingNCT07357948Not applicable
- Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTARecruitingNCT05354765Not applicable
- Adherence to Enteral NutritionRecruitingNCT07571564
- Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)RecruitingNCT04731610Not applicable
- ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer PatientsRecruitingNCT06195709Phase 3
- Cutting Edge Imaging With PET-FAPI for Earlier Pancreatic Cancer Diagnosis (INDIGO-FAPI)RecruitingNCT06659705Phase 2
- Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4RecruitingNCT05088395Not applicable
- Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast CancerRecruitingNCT07193394Phase 2
- Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric OncologyRecruitingNCT05781295Not applicable
- Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)RecruitingNCT03017573Not applicable
- Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.RecruitingNCT05439005Phase 3
- Efficacy of Personalized Tumorogram-based Therapy in Cancer Established From Patient-derived Organoid (AVATAR)RecruitingNCT06459791Not applicable
- Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut CurieRecruitingNCT07357311
- 68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)RecruitingNCT06349512Not applicable
- Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual OutcomeRecruitingNCT04681417Phase 2/3
- LIquid Biopsy to prEdict Responses To First-line immunotherapY in Metastatic Non-small Cell LUNG Cancer. LIBERTY LUNGRecruitingNCT04790682Not applicable
- Skin Reactions Related to Thoracic Implantable Chamber DressingsRecruitingNCT07158879
- Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)RecruitingNCT04424719Not applicable
- Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.Not yet recruitingNCT07111117Phase 2
- SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic TumoursRecruitingNCT05192980Not applicable
- Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast CancerRecruitingNCT05955170Phase 2
- Patient Experience and Quality of Life During the Surveillance Phase of Uveal Melanoma: A Prospective Multi-method StudyNot yet recruitingNCT06073548
- LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)Active, not recruitingNCT04446962Phase 1/2
- Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic SignaturesActive, not recruitingNCT05475366Not applicable
- Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)CompletedNCT05282901Phase 2
- Digital Phenotyping in Women Over 70 Years of Age Treated for Breast Cancer With Any Type of TreatmentCompletedNCT05634395Not applicable
- First-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide)CompletedNCT04733027Early Phase 1
- Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)CompletedNCT03739775Not applicable
- Comparative Evaluation of Care Strategies on Dressing Change-induced Bleeding in Patients With Bleeding Malignant Wounds (Tumoss)TerminatedNCT06581809Not applicable
- Tiragolumab, Atezolizumab and Chemotherapy in Triple Negative Breast CancerActive, not recruitingNCT06175390Phase 2
- Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)Active, not recruitingNCT02870907Phase 2
- A Study on Tuvusertib (Oral ATR Inhibitor) in Combination With PLX038 (Topo1 Inhibitor) in Patients With Advanced Solid TumorsTerminatedNCT06337630Phase 1
- A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Triple-negative Breast CancerTerminatedNCT06162351Phase 2
- Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.Active, not recruitingNCT04823377Not applicable
- Olaparib & Radiation Therapy for Patients Triple Negative Breast Cancer (TNBC)CompletedNCT03109080Phase 1
- Assessment of Response to Neo-adjuvant Chemotherapy for Patients With a Locally Advanced Breast Cancer With 3D Elastography (Shear Wave), NEOELASTOCompletedNCT02834494Not applicable
- Characterisation of Biofilm of the Chronic WoundsCompletedNCT02519166Not applicable
- A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)CompletedNCT02244125Phase 2
- A Randomized Phase II Trial Comparing Therapy Based on Tumor Molecular Profiling Versus Conventional Therapy in Patients With Refractory CancerCompletedNCT01771458Phase 2
- Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous MeningitisCompletedNCT01373710Phase 1/2
- Breast Cancer Risk After Diagnostic Gene SequencingCompletedNCT04145817Not applicable
- Post-occlusive Reactive Hyperemia and Basal-cell CarcinomaCompletedNCT01455363Not applicable
- Conservative Treatments of RetinoblastomaActive, not recruitingNCT02866136Phase 2
- Study of Circulating Tumoral DNA in Metastatic Choroidal MelanomaCompletedNCT01334008Not applicable